Abiopharma

🔍 PORTNOY DAVID (Executive)

Company: CRYO CELL INTERNATIONAL INC (CCEL)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Sold 15,611 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: J | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | shares_owned_after: 804,742.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | nature_of_ownership: By 401K | shares_owned_after: 164,182.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 247,757.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 102,586.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | nature_of_ownership: By LLC | shares_owned_after: 59,027.00 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | nature_of_ownership: By Corporation | shares_owned_after: 55,219.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | nature_of_ownership: As Custodian for son | shares_owned_after: 11,352.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | nature_of_ownership: As Custodian for son | shares_owned_after: 11,242.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | nature_of_ownership: As Custodian for son | shares_owned_after: 10,783.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | nature_of_ownership: As Custodian for daughter | shares_owned_after: 15,611.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | nature_of_ownership: By Corporation | shares_owned_after: 152,882.00 | Footnotes: F3
• Holds 26,243 shares of Stock Option at $7.53 per share (Derivative)
  Date: 2025-09-02 | Code: H | Expires: 2029-08-30 | Exercise: 2019-08-30 | shares_owned_after: 26,243.00
• Holds 23,636 shares of Stock Option at $7.28 per share (Derivative)
  Date: 2025-09-02 | Code: H | Expires: 2029-12-20 | Exercise: 2019-12-20 | shares_owned_after: 23,636.00
• Holds 280,000 shares of Stock Option at $12.27 per share (Derivative)
  Date: 2025-09-02 | Code: H | Expires: 2028-12-22 | Exercise: 2021-12-22 | shares_owned_after: 280,000.00 | Footnotes: F5
• Holds 50,000 shares of Stock Option at $4.77 per share (Derivative)
  Date: 2025-09-02 | Code: H | Expires: 2028-01-03 | Exercise: 2023-01-03 | shares_owned_after: 50,000.00 | Footnotes: F6
• Holds 50,000 shares of Stock Option at $4.3 per share (Derivative)
  Date: 2025-09-02 | Code: H | Expires: 2027-12-23 | Exercise: 2022-12-23 | shares_owned_after: 50,000.00
• Holds 50,000 shares of Stock Option at $6.47 per share (Derivative)
  Date: 2025-09-02 | Code: H | Expires: 2028-12-22 | Exercise: 2023-12-22 | shares_owned_after: 50,000.00 | Footnotes: F7
• Holds 50,000 shares of Stock Option at $8.08 per share (Derivative)
  Date: 2025-09-02 | Code: H | Expires: 2030-01-21 | Exercise: 2025-01-21 | shares_owned_after: 50,000.00 | Footnotes: F8

Footnotes:

• F1: Shares of common stock held by Mayim Limited Partnership as is David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.
• F2: Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary.
• F3: Shares of Common Stock held by PartnerCommunity, Inc., as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary.
• F4: Child reached age of majority and reporting person no longer has beneficial ownership.
• F5: Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
• F6: 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
• F7: Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
• F8: Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.